Highlights from the 8th annual conference on retroviruses and opportunistic infections.
Bartnof
H S
HS
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use; D003906:Developing Countries; D004334:Drug Administration Schedule; D004347:Drug Interactions; D018565:Food-Drug Interactions; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006509:Hepatitis B / Q000150:complications; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D010344:Patient Advocacy
D000276:Adjuvants, Immunologic; D019380:Anti-HIV Agents